AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
BioNTech SE American Depositary Share
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00Q70B4L0
88.12▼ 1.56 (-1.73%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
89.67
Day's Range
87.52 – 89.86
52-Week Range
79.50 – 124.00
Volume
827.8K
Avg Volume
1.0M
Share Statistics
Shares Outstanding
Employees
7,807
Exchange
XNAS
Listed
2019-10-10
Share count as of March 27, 2026

BioNTech SE American Depositary Share (BNTX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about BioNTech SE American Depositary Share (BNTX)
What is BioNTech SE American Depositary Share's Market Cap?
BioNTech SE American Depositary Share's Market Cap is $22.1B, based on as-reported figures from SEC (XBRL) filings.
What is BioNTech SE American Depositary Share's Price / Sales?
BioNTech SE American Depositary Share's Price / Sales is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is BioNTech SE American Depositary Share's Revenue (TTM)?
BioNTech SE American Depositary Share's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is BioNTech SE American Depositary Share's Net Income (TTM)?
BioNTech SE American Depositary Share's Net Income (TTM) is -$1.3B, based on as-reported figures from SEC (XBRL) filings.
What is BioNTech SE American Depositary Share's Diluted EPS (TTM)?
BioNTech SE American Depositary Share's Diluted EPS (TTM) is -5.31, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BNTXAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of EUR, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Profit or loss [abstract]
Revenues
Cost of sales
Research and development expenses
Sales and marketing expenses
General and administrative expenses
Other operating expenses
Other operating income
Operating profit / (loss)
Finance income
Finance expenses
Profit / (Loss) before tax
Income taxes
Net profit / (loss)
Earnings / (Loss) per share
Basic earnings for the period per share (in euros per share)
Diluted earnings for the period per share (in euros per share)